Body Worn Insect Repellents Market by Product Type (Lotion, Patch, Spray), Active Ingredient (Deet, Ir3535, Oil Of Lemon Eucalyptus), Packaging Type, End User, Distribution Channel, Sales Mode - Global Forecast 2025-2032
Description
The Body Worn Insect Repellents Market was valued at USD 577.98 million in 2024 and is projected to grow to USD 631.25 million in 2025, with a CAGR of 9.37%, reaching USD 1,183.73 million by 2032.
Introduction outlining how product innovation, consumer behavior shifts, regulatory dynamics, and retail evolution are converging to redefine body-worn insect repellent strategies
The increasing global attention on personal protection against insect-borne diseases and nuisance biting insects has elevated body-worn insect repellents from seasonal commodities to strategic product categories within consumer health and outdoor lifestyle portfolios. Innovation in active chemistries and formulation technologies has converged with heightened consumer expectations for convenience, safety, and sustainability, prompting manufacturers to recalibrate product claims, packaging formats, and channel strategies. At the same time, regulatory scrutiny and label harmonization efforts are reshaping the permissible claims and testing regimes that underpin product launches and cross-border trade.
As a result, companies operating in this space must balance efficacy, user experience, and compliance while navigating complex supply chains and shifting retail dynamics. Emerging consumer segments-ranging from urban commuters seeking low-odor formats to outdoor enthusiasts demanding long-duration protection-require differentiated approaches to product design and messaging. Moreover, digital channels and omnichannel retailing are amplifying the need for clear, evidence-backed differentiation amid intensifying competition. Consequently, understanding the interplay among formulation science, regulatory frameworks, consumer behavior, and distribution logistics is essential for stakeholders aiming to sustain growth and resilience in this evolving category.
Transformative shifts in formulation technology, sustainability expectations, and omnichannel retailing that are reshaping product development and go-to-market approaches
The landscape for body-worn insect repellents is undergoing transformative shifts driven by advances in formulation science, heightened sustainability expectations, and the rise of digitally native purchasing behaviors. Novel actives and delivery systems are enabling more user-friendly products such as long-duration sprays, discreet patch formats, and skin-friendly lotions designed for sensitive populations. At the same time, environmental stewardship is influencing ingredient selection and packaging design; compostable substrates, reduced-propellant aerosols, and concentrated formats that lower transport emissions are becoming differentiators for brands seeking to align with consumer values.
Simultaneously, retail ecosystems are evolving: online channels provide richer product education and review-driven credibility while brick-and-mortar outlets continue to play a critical role in trial and impulse purchasing. This omnichannel reality is prompting manufacturers to harmonize messaging and sample strategies across digital and physical touchpoints. Regulatory trends toward standardized efficacy testing and clearer labeling requirements are also accelerating. Therefore, companies that invest in integrated R&D, transparent communication, and supply chain agility will be better positioned to capitalize on shifting demand patterns and to outpace competitors constrained by legacy manufacturing or limited channel reach.
Cumulative effects of new trade measures on procurement, production flexibility, inventory strategies, and product assortment decisions across the body-worn repellent supply chain
The introduction of tariffs and trade measures in 2025 has amplified the need for resilience in supply chain design and procurement strategies across the personal protection sector. Cost pressures stemming from import duties on specific raw materials, packaging substrates, or finished goods have prompted purchasers to re-evaluate sourcing geographies and to explore alternative suppliers closer to end markets. In response, procurement teams are increasingly segmenting suppliers by strategic criticality, negotiating long-term agreements with cost pass-through mechanisms, and accelerating qualification of regional manufacturing partners to reduce exposure to single-country disruption.
Furthermore, tariffs have had a downstream effect on product assortment decisions and inventory policies. Retailers and distributors have been incentivized to rationalize SKUs that carry higher landed costs while favoring versatile formats that serve multiple consumer use cases. At the same time, manufacturers are exploring formulation tweaks that preserve performance while substituting tariff-exposed inputs with comparable, locally available alternatives. These adaptations have been coupled with strategic inventory buffering and dual-sourcing tactics to maintain continuity during peak seasons. Looking ahead, firms that combine tariff-aware sourcing, scenario-based cost modeling, and modular production planning will be better equipped to mitigate the cumulative impacts of trade actions and to preserve both margin performance and product availability.
Actionable segmentation insights showing how different sales modes, end-user needs, active ingredients, packaging formats, product variants, and distribution channels dictate strategy
Segmentation analyses reveal nuanced demand dynamics and usage patterns that inform targeted product development and channel strategies. Based on Sales Mode, consumer preference segmentation shows offline channels retaining an important role for trial and immediate need purchases while online channels drive research-led conversions and recurring subscriptions. Based on End User, differences between adult and child formulations continue to influence ingredient selection, safety testing, and labeling language, with caregivers prioritizing gentle, hypoallergenic formats for younger users. Based on Active Ingredient, DEET remains a durability benchmark while alternatives such as IR3535, Oil of Lemon Eucalyptus, and Picaridin are gaining traction for consumers seeking lower-odor, reef-friendly, or dermatologically milder options.
Based on Packaging Type, format choices such as aerosol, pump spray, roll-on, and wipe packs affect use-case suitability, dosing control, and travel compliance, shaping where products are recommended and how they are merchandised. Based on Product Type, diverse offerings including lotions, patches, sprays, wipes, and wristbands highlight the importance of convenient, context-specific protection; for instance, patches and wristbands address hands-free requirements for active users while lotions and sprays remain dominant for sustained coverage. Finally, based on Distribution Channel, the presence of convenience stores, online retail, pharmacy drug stores, specialty stores, and supermarket hypermarket chains influences assortment breadth, promotional cycles, and private-label penetration, underscoring the necessity of channel-specific value propositions and logistics partnerships.
Regional demand drivers and operational imperatives across the Americas, Europe Middle East & Africa, and Asia-Pacific that determine localized product and channel strategies
Regional dynamics exert a strong influence on product design, regulatory compliance, and go-to-market approaches across the Americas, Europe Middle East & Africa, and Asia-Pacific. In the Americas, consumer awareness of vector-borne disease risks and a well-established retail infrastructure favor evidence-backed formulations, broad-format assortments, and seasonal promotional campaigns that align with outdoor leisure patterns. In contrast, Europe Middle East & Africa presents a mosaic of regulatory frameworks and consumer preferences that require localized labeling, ingredient approvals, and nuanced positioning that respects diverse language and cultural considerations. In many EMEA markets, demand for eco-conscious formulations and clear safety credentials is pronounced, prompting brands to foreground scientific validation and sustainability proof points.
Asia-Pacific is characterized by high usage in both urban and rural contexts, with rising urban affluence driving interest in premium, convenient formats and strong growth in digital commerce. Regional supply chain hubs in Asia-Pacific also influence global sourcing decisions, reinforcing the interplay between production geography and product availability in other regions. Across these territories, seasonality, endemic disease patterns, and retail sophistication vary, necessitating region-specific product mixes, regulatory strategies, and commercial partnerships. Therefore, firms pursuing international expansion must adopt agile regional playbooks that integrate local regulatory expertise, consumer insights, and distribution partner capabilities to achieve sustained acceptance and operational efficiency.
Competitive intelligence and innovation patterns revealing how established brands, local specialists, and private-label offerings are intensifying category competition
Competitive dynamics in body-worn insect repellents are shaped by a mix of established global manufacturers, nimble local specialists, and emerging private-label entrants. Leading players leverage scale in R&D, clinical validation, and distribution relationships to maintain shelf prominence and to support premium positioning on efficacy and safety. At the same time, smaller innovators are capturing attention by targeting underserved niches-such as sensitive-skin formulations, pediatric-safe delivery systems, or eco-conscious packaging-and by using targeted digital marketing to build engaged communities of advocates.
Private-label programs are becoming more sophisticated, with retailers offering differentiated in-house formulations that compete on price and convenience, especially in high-frequency purchase channels. Strategic partnerships between ingredient specialists and consumer brands are accelerating product innovation, enabling rapid iterations of novel combinations of actives and delivery systems. Moreover, contract manufacturing and co-packing relationships are lowering barriers to entry, expanding assortment diversity, and compressing time-to-shelf for creative new offers. Collectively, these trends increase competitive intensity, reward brands that invest in credible efficacy claims and sustainability credentials, and heighten the importance of channel-tailored execution and supply chain reliability.
Clear and practical strategic recommendations for product developers, supply chain leaders, and commercial teams to drive growth, resilience, and regulatory readiness
To capitalize on evolving consumer needs and operational challenges, industry leaders should pursue a coordinated set of strategic actions. First, prioritize formulation and delivery system investment that balances long-duration efficacy with skin tolerability and environmental credentials; this will expand appeal across sensitive and performance-driven segments. Second, diversify sourcing and manufacturing footprints to reduce tariff exposure and to enable rapid response to regional demand spikes, while instituting supplier-risk monitoring and scenario planning. Third, develop differentiated channel strategies that tailor product assortments, pricing, and promotional mechanics to offline trial behaviors and online content-driven purchase journeys.
Additionally, invest in robust regulatory intelligence and pre-market validation workflows to accelerate approvals across jurisdictions and to substantiate on-pack claims that matter to consumers and regulators alike. Enhance digital-first commercialization capabilities by integrating consumer education content, user-generated evidence, and subscription models that drive repeat purchases. Finally, foster cross-functional collaboration between R&D, regulatory, and commercial teams to ensure that new product concepts are feasible, compliant, and aligned with retailer requirements-thereby shortening development cycles and improving launch success rates.
Rigorous mixed-method research methodology explaining data sources, primary interviews, secondary analysis, validation practices, and analytical frameworks supporting the study
The research approach combined primary qualitative and quantitative inquiry with systematic secondary research to ensure robust evidence synthesis and reproducibility. Primary inputs included structured interviews with formulation scientists, regulatory affairs specialists, procurement executives, and senior commercial leaders, supplemented by in-market retailer and distributor consultations to validate channel assumptions and assortment dynamics. Secondary research encompassed analysis of public regulatory guidance, patent filings, scientific literature on active ingredients, and logistics data to map supply chain touchpoints and cost levers.
Analytical frameworks focused on scenario-based stress testing of sourcing strategies, comparative assessment of ingredient performance profiles, and channel economics evaluation to understand margin variability across formats and distribution routes. Findings were triangulated using cross-validation techniques and subject-matter expert review to minimize bias and to ensure practical relevance. Throughout the process, data integrity protocols governed sample selection, interview documentation, and version control, ensuring that conclusions reflect a coherent synthesis of expert insight and empirical evidence appropriate for strategic decision-making.
Concluding synthesis of strategic priorities, unresolved uncertainties, and pragmatic next steps for stakeholders seeking durable advantage in the category
Taken together, the evidence underscores that success in the body-worn insect repellent category will rest on three interdependent capabilities: scientifically credible product innovation, adaptive supply chain design, and channel-aware commercialization. Firms that can rapidly iterate formulations while demonstrating safety and environmental stewardship will appeal to a broadening set of consumers who prioritize wellness and sustainability. Concurrently, supply chain flexibility-achieved through geographic diversification, modular manufacturing, and proactive tariff-aware procurement-will preserve product availability and margin stability amid external shocks. Finally, nuanced channel strategies that reconcile the strengths of offline trial with online education and repeat-purchase mechanisms will accelerate customer acquisition and lifetime value.
Remaining uncertainties include the pace of regulatory harmonization across jurisdictions, the evolution of consumer preferences in response to new actives, and potential further trade measures that could alter input costs. Nevertheless, organizations that adopt integrated product, regulatory, and commercial roadmaps-underpinned by scenario planning and continuous consumer insight-will be better positioned to navigate these variables and to secure competitive advantage in this dynamic category.
Note: PDF & Excel + Online Access - 1 Year
Introduction outlining how product innovation, consumer behavior shifts, regulatory dynamics, and retail evolution are converging to redefine body-worn insect repellent strategies
The increasing global attention on personal protection against insect-borne diseases and nuisance biting insects has elevated body-worn insect repellents from seasonal commodities to strategic product categories within consumer health and outdoor lifestyle portfolios. Innovation in active chemistries and formulation technologies has converged with heightened consumer expectations for convenience, safety, and sustainability, prompting manufacturers to recalibrate product claims, packaging formats, and channel strategies. At the same time, regulatory scrutiny and label harmonization efforts are reshaping the permissible claims and testing regimes that underpin product launches and cross-border trade.
As a result, companies operating in this space must balance efficacy, user experience, and compliance while navigating complex supply chains and shifting retail dynamics. Emerging consumer segments-ranging from urban commuters seeking low-odor formats to outdoor enthusiasts demanding long-duration protection-require differentiated approaches to product design and messaging. Moreover, digital channels and omnichannel retailing are amplifying the need for clear, evidence-backed differentiation amid intensifying competition. Consequently, understanding the interplay among formulation science, regulatory frameworks, consumer behavior, and distribution logistics is essential for stakeholders aiming to sustain growth and resilience in this evolving category.
Transformative shifts in formulation technology, sustainability expectations, and omnichannel retailing that are reshaping product development and go-to-market approaches
The landscape for body-worn insect repellents is undergoing transformative shifts driven by advances in formulation science, heightened sustainability expectations, and the rise of digitally native purchasing behaviors. Novel actives and delivery systems are enabling more user-friendly products such as long-duration sprays, discreet patch formats, and skin-friendly lotions designed for sensitive populations. At the same time, environmental stewardship is influencing ingredient selection and packaging design; compostable substrates, reduced-propellant aerosols, and concentrated formats that lower transport emissions are becoming differentiators for brands seeking to align with consumer values.
Simultaneously, retail ecosystems are evolving: online channels provide richer product education and review-driven credibility while brick-and-mortar outlets continue to play a critical role in trial and impulse purchasing. This omnichannel reality is prompting manufacturers to harmonize messaging and sample strategies across digital and physical touchpoints. Regulatory trends toward standardized efficacy testing and clearer labeling requirements are also accelerating. Therefore, companies that invest in integrated R&D, transparent communication, and supply chain agility will be better positioned to capitalize on shifting demand patterns and to outpace competitors constrained by legacy manufacturing or limited channel reach.
Cumulative effects of new trade measures on procurement, production flexibility, inventory strategies, and product assortment decisions across the body-worn repellent supply chain
The introduction of tariffs and trade measures in 2025 has amplified the need for resilience in supply chain design and procurement strategies across the personal protection sector. Cost pressures stemming from import duties on specific raw materials, packaging substrates, or finished goods have prompted purchasers to re-evaluate sourcing geographies and to explore alternative suppliers closer to end markets. In response, procurement teams are increasingly segmenting suppliers by strategic criticality, negotiating long-term agreements with cost pass-through mechanisms, and accelerating qualification of regional manufacturing partners to reduce exposure to single-country disruption.
Furthermore, tariffs have had a downstream effect on product assortment decisions and inventory policies. Retailers and distributors have been incentivized to rationalize SKUs that carry higher landed costs while favoring versatile formats that serve multiple consumer use cases. At the same time, manufacturers are exploring formulation tweaks that preserve performance while substituting tariff-exposed inputs with comparable, locally available alternatives. These adaptations have been coupled with strategic inventory buffering and dual-sourcing tactics to maintain continuity during peak seasons. Looking ahead, firms that combine tariff-aware sourcing, scenario-based cost modeling, and modular production planning will be better equipped to mitigate the cumulative impacts of trade actions and to preserve both margin performance and product availability.
Actionable segmentation insights showing how different sales modes, end-user needs, active ingredients, packaging formats, product variants, and distribution channels dictate strategy
Segmentation analyses reveal nuanced demand dynamics and usage patterns that inform targeted product development and channel strategies. Based on Sales Mode, consumer preference segmentation shows offline channels retaining an important role for trial and immediate need purchases while online channels drive research-led conversions and recurring subscriptions. Based on End User, differences between adult and child formulations continue to influence ingredient selection, safety testing, and labeling language, with caregivers prioritizing gentle, hypoallergenic formats for younger users. Based on Active Ingredient, DEET remains a durability benchmark while alternatives such as IR3535, Oil of Lemon Eucalyptus, and Picaridin are gaining traction for consumers seeking lower-odor, reef-friendly, or dermatologically milder options.
Based on Packaging Type, format choices such as aerosol, pump spray, roll-on, and wipe packs affect use-case suitability, dosing control, and travel compliance, shaping where products are recommended and how they are merchandised. Based on Product Type, diverse offerings including lotions, patches, sprays, wipes, and wristbands highlight the importance of convenient, context-specific protection; for instance, patches and wristbands address hands-free requirements for active users while lotions and sprays remain dominant for sustained coverage. Finally, based on Distribution Channel, the presence of convenience stores, online retail, pharmacy drug stores, specialty stores, and supermarket hypermarket chains influences assortment breadth, promotional cycles, and private-label penetration, underscoring the necessity of channel-specific value propositions and logistics partnerships.
Regional demand drivers and operational imperatives across the Americas, Europe Middle East & Africa, and Asia-Pacific that determine localized product and channel strategies
Regional dynamics exert a strong influence on product design, regulatory compliance, and go-to-market approaches across the Americas, Europe Middle East & Africa, and Asia-Pacific. In the Americas, consumer awareness of vector-borne disease risks and a well-established retail infrastructure favor evidence-backed formulations, broad-format assortments, and seasonal promotional campaigns that align with outdoor leisure patterns. In contrast, Europe Middle East & Africa presents a mosaic of regulatory frameworks and consumer preferences that require localized labeling, ingredient approvals, and nuanced positioning that respects diverse language and cultural considerations. In many EMEA markets, demand for eco-conscious formulations and clear safety credentials is pronounced, prompting brands to foreground scientific validation and sustainability proof points.
Asia-Pacific is characterized by high usage in both urban and rural contexts, with rising urban affluence driving interest in premium, convenient formats and strong growth in digital commerce. Regional supply chain hubs in Asia-Pacific also influence global sourcing decisions, reinforcing the interplay between production geography and product availability in other regions. Across these territories, seasonality, endemic disease patterns, and retail sophistication vary, necessitating region-specific product mixes, regulatory strategies, and commercial partnerships. Therefore, firms pursuing international expansion must adopt agile regional playbooks that integrate local regulatory expertise, consumer insights, and distribution partner capabilities to achieve sustained acceptance and operational efficiency.
Competitive intelligence and innovation patterns revealing how established brands, local specialists, and private-label offerings are intensifying category competition
Competitive dynamics in body-worn insect repellents are shaped by a mix of established global manufacturers, nimble local specialists, and emerging private-label entrants. Leading players leverage scale in R&D, clinical validation, and distribution relationships to maintain shelf prominence and to support premium positioning on efficacy and safety. At the same time, smaller innovators are capturing attention by targeting underserved niches-such as sensitive-skin formulations, pediatric-safe delivery systems, or eco-conscious packaging-and by using targeted digital marketing to build engaged communities of advocates.
Private-label programs are becoming more sophisticated, with retailers offering differentiated in-house formulations that compete on price and convenience, especially in high-frequency purchase channels. Strategic partnerships between ingredient specialists and consumer brands are accelerating product innovation, enabling rapid iterations of novel combinations of actives and delivery systems. Moreover, contract manufacturing and co-packing relationships are lowering barriers to entry, expanding assortment diversity, and compressing time-to-shelf for creative new offers. Collectively, these trends increase competitive intensity, reward brands that invest in credible efficacy claims and sustainability credentials, and heighten the importance of channel-tailored execution and supply chain reliability.
Clear and practical strategic recommendations for product developers, supply chain leaders, and commercial teams to drive growth, resilience, and regulatory readiness
To capitalize on evolving consumer needs and operational challenges, industry leaders should pursue a coordinated set of strategic actions. First, prioritize formulation and delivery system investment that balances long-duration efficacy with skin tolerability and environmental credentials; this will expand appeal across sensitive and performance-driven segments. Second, diversify sourcing and manufacturing footprints to reduce tariff exposure and to enable rapid response to regional demand spikes, while instituting supplier-risk monitoring and scenario planning. Third, develop differentiated channel strategies that tailor product assortments, pricing, and promotional mechanics to offline trial behaviors and online content-driven purchase journeys.
Additionally, invest in robust regulatory intelligence and pre-market validation workflows to accelerate approvals across jurisdictions and to substantiate on-pack claims that matter to consumers and regulators alike. Enhance digital-first commercialization capabilities by integrating consumer education content, user-generated evidence, and subscription models that drive repeat purchases. Finally, foster cross-functional collaboration between R&D, regulatory, and commercial teams to ensure that new product concepts are feasible, compliant, and aligned with retailer requirements-thereby shortening development cycles and improving launch success rates.
Rigorous mixed-method research methodology explaining data sources, primary interviews, secondary analysis, validation practices, and analytical frameworks supporting the study
The research approach combined primary qualitative and quantitative inquiry with systematic secondary research to ensure robust evidence synthesis and reproducibility. Primary inputs included structured interviews with formulation scientists, regulatory affairs specialists, procurement executives, and senior commercial leaders, supplemented by in-market retailer and distributor consultations to validate channel assumptions and assortment dynamics. Secondary research encompassed analysis of public regulatory guidance, patent filings, scientific literature on active ingredients, and logistics data to map supply chain touchpoints and cost levers.
Analytical frameworks focused on scenario-based stress testing of sourcing strategies, comparative assessment of ingredient performance profiles, and channel economics evaluation to understand margin variability across formats and distribution routes. Findings were triangulated using cross-validation techniques and subject-matter expert review to minimize bias and to ensure practical relevance. Throughout the process, data integrity protocols governed sample selection, interview documentation, and version control, ensuring that conclusions reflect a coherent synthesis of expert insight and empirical evidence appropriate for strategic decision-making.
Concluding synthesis of strategic priorities, unresolved uncertainties, and pragmatic next steps for stakeholders seeking durable advantage in the category
Taken together, the evidence underscores that success in the body-worn insect repellent category will rest on three interdependent capabilities: scientifically credible product innovation, adaptive supply chain design, and channel-aware commercialization. Firms that can rapidly iterate formulations while demonstrating safety and environmental stewardship will appeal to a broadening set of consumers who prioritize wellness and sustainability. Concurrently, supply chain flexibility-achieved through geographic diversification, modular manufacturing, and proactive tariff-aware procurement-will preserve product availability and margin stability amid external shocks. Finally, nuanced channel strategies that reconcile the strengths of offline trial with online education and repeat-purchase mechanisms will accelerate customer acquisition and lifetime value.
Remaining uncertainties include the pace of regulatory harmonization across jurisdictions, the evolution of consumer preferences in response to new actives, and potential further trade measures that could alter input costs. Nevertheless, organizations that adopt integrated product, regulatory, and commercial roadmaps-underpinned by scenario planning and continuous consumer insight-will be better positioned to navigate these variables and to secure competitive advantage in this dynamic category.
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
198 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency
- 1.5. Language
- 1.6. Stakeholders
- 2. Research Methodology
- 3. Executive Summary
- 4. Market Overview
- 5. Market Insights
- 5.1. Rapid adoption of plant-based and natural ingredient body worn repellents by health-conscious consumers
- 5.2. Integration of wearable electronics and smart sensors in insect repellent devices for real-time protection monitoring
- 5.3. Growth in subscription models and refillable wearable repellent devices to reduce packaging waste
- 5.4. Expansion of multifunctional outdoor activity wear combining insect repellency with UV protection and moisture-wicking
- 5.5. Increasing demand for child-friendly wearable repellent accessories with fun designs and FDA-approved formulations
- 5.6. Surge in demand for contactless repellent bracelets leveraging nanotechnology for extended protection duration
- 5.7. Rising consumer preference for fragrance-free and hypoallergenic wearable insect repellent products for sensitive skin
- 5.8. Regulatory scrutiny driving reformulation of wearable repellents to comply with global safety and environmental standards
- 6. Cumulative Impact of United States Tariffs 2025
- 7. Cumulative Impact of Artificial Intelligence 2025
- 8. Body Worn Insect Repellents Market, by Product Type
- 8.1. Lotion
- 8.2. Patch
- 8.3. Spray
- 8.4. Wipe
- 8.5. Wristband
- 9. Body Worn Insect Repellents Market, by Active Ingredient
- 9.1. Deet
- 9.2. Ir3535
- 9.3. Oil Of Lemon Eucalyptus
- 9.4. Picaridin
- 10. Body Worn Insect Repellents Market, by Packaging Type
- 10.1. Aerosol
- 10.2. Pump Spray
- 10.3. Roll On
- 10.4. Wipe Pack
- 11. Body Worn Insect Repellents Market, by End User
- 11.1. Adult
- 11.2. Child
- 12. Body Worn Insect Repellents Market, by Distribution Channel
- 12.1. Convenience Store
- 12.2. Online Retail
- 12.3. Pharmacy Drug Store
- 12.4. Specialty Store
- 12.5. Supermarket Hypermarket
- 13. Body Worn Insect Repellents Market, by Sales Mode
- 13.1. Offline
- 13.2. Online
- 14. Body Worn Insect Repellents Market, by Region
- 14.1. Americas
- 14.1.1. North America
- 14.1.2. Latin America
- 14.2. Europe, Middle East & Africa
- 14.2.1. Europe
- 14.2.2. Middle East
- 14.2.3. Africa
- 14.3. Asia-Pacific
- 15. Body Worn Insect Repellents Market, by Group
- 15.1. ASEAN
- 15.2. GCC
- 15.3. European Union
- 15.4. BRICS
- 15.5. G7
- 15.6. NATO
- 16. Body Worn Insect Repellents Market, by Country
- 16.1. United States
- 16.2. Canada
- 16.3. Mexico
- 16.4. Brazil
- 16.5. United Kingdom
- 16.6. Germany
- 16.7. France
- 16.8. Russia
- 16.9. Italy
- 16.10. Spain
- 16.11. China
- 16.12. India
- 16.13. Japan
- 16.14. Australia
- 16.15. South Korea
- 17. Competitive Landscape
- 17.1. Market Share Analysis, 2024
- 17.2. FPNV Positioning Matrix, 2024
- 17.3. Competitive Analysis
- 17.3.1. 3M Company
- 17.3.2. Babyhug
- 17.3.3. Bushman Repellent
- 17.3.4. Coghlan’s Ltd.
- 17.3.5. Dabur International Limited
- 17.3.6. Enesis Group
- 17.3.7. ExOfficio LLC,
- 17.3.8. Forest Essentials
- 17.3.9. Heritancy Manufacturers
- 17.3.10. Himalaya Wellness Company
- 17.3.11. Honasa Consumer Limited
- 17.3.12. Incognito
- 17.3.13. Jungle Formula by Perrigo Company plc
- 17.3.14. MACROVITA.pl
- 17.3.15. Merck KGaA
- 17.3.16. Mirah Belle Naturals & Apothecary Pvt. Ltd.
- 17.3.17. Mother Sparsh Baby Care Private Limited
- 17.3.18. MyVitaly s.r.l.
- 17.3.19. Nature’s Botanical
- 17.3.20. Newell Brands Inc.
- 17.3.21. Oleum Cottage
- 17.3.22. S. C. Johnson & Son, Inc.
- 17.3.23. Sawyer
- 17.3.24. Shantou S.E.Z Baojie Industrial Co., Ltd
- 17.3.25. Swadesh International
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
